Thienyl and Phenyl α-Halomethyl Ketones: New Inhibitors of Glycogen Synthase Kinase (GSK-3β) from a Library of Compound SearchingSantiago Conde, Francisco J. Moreno, Daniel I. Pérez et al.|Journal of Medicinal Chemistry|2003Cited by 99
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.José Á. Morales-García, Ana Pérez‐Castillo, Ángel Santos et al.|ACS Chemical Neuroscience|2012Cited by 81
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitorsAna Martı́nez, Albert Badı́a, Enrique J. Gómez Fernández et al.|European Journal of Medicinal Chemistry|2000Cited by 78
Switching Reversibility to Irreversibility in Glycogen Synthase Kinase 3 Inhibitors: Clues for Specific Design of New CompoundsDaniel I. Pérez, Ana Martı́nez, Concepción Pérez et al.|Journal of Medicinal Chemistry|2011Cited by 73
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological toolsDaniel I. Pérez, Ana Martı́nez, Santiago Conde et al.|Bioorganic & Medicinal Chemistry|2009Cited by 57